ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
실시간 혈당 측정 CGM 패치 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 61억 2,000만 달러로 평가되었고, 2025년에는 70억 4,000만 달러에 달하고, CAGR 15.0%로 성장할 전망입니다. 지난 몇 년간의 성장은 보험 적용 범위의 확대, 강력한 임상적 증거 기반, 의료 종사자의 훈련과 숙련도 향상, 재택 만성 질환 관리로의 전환, 전문 가이드라인에서의 추천 등이 요인으로 들 수 있습니다.
실시간 혈당 측정 CGM 패치 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 14.6%의 연평균 복합 성장률(CAGR)로 121억 4,000만 달러에 달할 전망입니다. 예측기간 동안의 성장요인으로는 전당뇨병 스크리닝 증가와 조기진단의 진전, 인슐린 사용자 및 비인슐린 사용자에 대한 보험 적용 범위의 확대, 혈당 조절 시간과 관련된 가치에 기초한 의료 인센티브, 대사 질환 부담 증가를 수반하는 고령화, 신흥 경제국에서의 도시화와 식생활의 변화를 들 수 있습니다. 예측 기간의 주요 동향으로는 2주를 넘는 장기 장착형 패치 센서, 패치형 연속 혈당 모니터링과 자동 인슐린 투여 시스템의 통합, 스마트폰에 의존하지 않는 직접 시계 접속 기능, 신체 장착형 진동·눈에 띄지 않는 경고 기술, 피부 자극을 경감하는 선진의 생체 적합성 접착제 등을 들 수 있습니다.
당뇨병의 유병률 상승은 실시간 혈당 측정 CGM 패치 시장의 성장을 이끌 것으로 예측됩니다. 당뇨병은 인슐린 생산 부족 또는 인슐린 저항성으로 인한 고혈당을 특징으로 하는 만성 대사 질환입니다. 비만률의 상승은 인슐린 저항성을 높이고, 혈당 조절을 방해하고, 2형 당뇨병 발병 위험을 현저하게 증가시키기 때문에 그 유병률은 증가 경향에 있습니다. 실시간 혈당 CGM 패치는 당뇨병 환자가 혈당 수치를 지속적으로 모니터링하고 고혈당 및 저혈당에 대한 적시 경고를 제공합니다. 이를 통해 식사, 약물 요법 및 생활 습관에 대한 정보를 기반으로 판단을 지원하고 합병증 위험을 줄이면서 전체 질병 관리 개선에 기여합니다. 예를 들어, 2024년 6월에 영국 국민보건서비스(NHS)는 2023년 영국에서 새롭게 54만 9,000명 이상이 2형 당뇨병의 위험이 있다고 확인되었다고 보고했습니다. 이에 따라 의사에게 등록된 비당뇨병성 고혈당 또는 전당뇨병 환자 수는 2022년 306만 5,825명에서 약 20% 증가하여 361만 5,330명에 달했습니다. 이것은 당뇨병의 유병률 상승이 시장 성장을 견인하는 실태를 보여줍니다.
실시간 혈당 CGM 패치 시장의 주요 기업은 접근성과 편리성을 높이기 위해 시중에서 판매되는 연속 혈당 모니터링 센서와 같은 혁신적인 제품에 주력하고 있습니다. 시중에서 판매되는 CGM 센서는 처방전이 필요 없는 혈당를 실시간으로 추적하는 웨어러블 디바이스로, 사용자가 지속적으로 혈당를 모니터링하고, 생활습관의 영향을 이해하고, 당뇨병 관리 및 예방을 보다 용이하게 할 수 있습니다. 예를 들어, 2024년 9월에는 미국에 본사를 둔 당뇨병 기술 기업인 덱콤사가 이 회사 최초의 OTC CGM 패치 스테로를 미국에서 발매했습니다. 이 소형 웨어러블 센서는 상완 뒷면에 장착되어 손가락 끝 천자없이 스마트폰 앱에 직접 실시간 혈당을 제공합니다. 인슐린을 사용하지 않는 2형 당뇨병 환자 및 전 당뇨병 상태를 대상으로 설계된 스테로는 식사·운동·수면이 혈당에 미치는 영향에 관한 개인별 분석을 제공합니다. 최대 15일간의 장착이 가능하며 방수 사양, 혈당의 급상승 및 패턴 검출 기능을 갖추고 덱콤사의 혈당 측정 기술과 연계함으로써 보다 광범위한 층에 있어서 연속 혈당 모니터링을 보다 친숙하고 실천적인 것으로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 실시간 혈당 측정 CGM 패치 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 실시간 혈당 측정 CGM 패치 시장 : 성장률 분석
세계의 실시간 혈당 측정 CGM 패치 시장 실적 : 규모와 성장, 2019-2024
세계의 실시간 혈당 측정 CGM 패치 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 실시간 혈당 측정 CGM 패치 시장 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 실시간 혈당 측정 CGM 패치 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
웨어러블 CGM 패치
이식형 CGM 패치
세계의 실시간 혈당 측정 CGM 패치 시장 : 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
효소적
비효소식
세계의 실시간 혈당 측정 CGM 패치 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
온라인 약국
소매 약국
병원 약국
기타 유통 채널
세계의 실시간 혈당 측정 CGM 패치 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
1형 당뇨병
2형 당뇨병
임신성 당뇨
기타 용도
세계의 실시간 혈당 측정 CGM 패치 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 및 진료소
재택치료 환경
진단센터
기타 최종 사용자
세계의 실시간 혈당 측정 CGM 패치 시장 : 세분화 웨어러블 CGM 패치, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
센서 내장형 웨어러블 CGM 패치
블루투스 대응 웨어러블 CGM 패치
모바일 연결형 웨어러블 CGM 패치
원격 의료 대응 웨어러블 CGM 패치
세계의 실시간 혈당 측정 CGM 패치 시장 : 세분화 이식형 CGM 패치, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
피하 이식형 CGM 패치
장기 이식형 CGM 패치
소형화 이식형 CGM 패치
원격 감시형 임베디드 CGM 패치
제7장 지역별/국가별 분석
세계의 실시간 혈당 측정 CGM 패치 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 실시간 혈당 측정 CGM 패치 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
실시간 혈당 측정 CGM 패치 시장 : 경쟁 구도
실시간 혈당 측정 CGM 패치 시장 : 기업 프로파일
F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Dexcom Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Trinity Biotech plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Biolinq Inc.
Ascensia Diabetes Care Holdings AG
Senseonics Holdings Inc.
A. Menarini Diagnostics Srl
RSP Systems A/S
OrSense Ltd.
Rockley Photonics Holdings Ltd.
Sinocare Inc.
CNOGA Medical Ltd.
Medtrum Technologies Inc.
Nutromics Ltd.
Nemaura Medical Inc.
DiaMonTech GmbH
Movano Health Inc.
GlucoRx Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
실시간 혈당 측정 CGM 패치 시장 2029 : 새로운 기회를 제공하는 국가
실시간 혈당 측정 CGM 패치 시장 2029 : 새로운 기회를 제공하는 부문
실시간 혈당 측정 CGM 패치 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
A real-time blood glucose continuous glucose monitoring (CGM) patch is a wearable device that continuously monitors glucose levels in the interstitial fluid beneath the skin. It transmits glucose readings in real time to a connected display or mobile device, enabling continuous tracking of glucose trends. The patch functions through a small sensor and transmitter that provide frequent data updates without requiring fingerstick measurements.
The primary product types of real-time blood glucose continuous glucose monitoring (CGM) patches are wearable CGM patches and implantable CGM patches. A wearable CGM patch is a discreet, skin-worn sensor that continuously tracks glucose levels and transmits real-time data to support management of diet, activity, and medication. These patches incorporate various technologies, including enzymatic and non-enzymatic systems, and are distributed through channels such as online pharmacies, retail pharmacies, hospital pharmacies, and other outlets. They are used for applications including type 1 diabetes, type 2 diabetes, gestational diabetes, and other conditions, and are utilized by hospitals, clinics, homecare settings, diagnostic centers, and other end-users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The real-time blood glucose continuous glucose monitoring (CGM) patch market research report is one of a series of new reports from The Business Research Company that provides real-time blood glucose continuous glucose monitoring (CGM) patch market statistics, including real-time blood glucose continuous glucose monitoring (CGM) patch industry global market size, regional shares, competitors with the real-time blood glucose continuous glucose monitoring (CGM) patch market share, real-time blood glucose continuous glucose monitoring (CGM) patch market segments, market trends, and opportunities, and any further data you may need to thrive in the real-time blood glucose continuous glucose monitoring (CGM) patch industry. This real-time blood glucose continuous glucose monitoring (CGM) patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The real-time blood glucose continuous glucose monitoring (CGM) patch market size has grown rapidly in recent years. It will grow from $6.12 billion in 2024 to $7.04 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth during the historic period can be attributed to broader reimbursement coverage, a strong clinical evidence base, clinician training and familiarity, a shift toward home-based chronic care, and endorsement in professional guidelines.
The real-time blood glucose continuous glucose monitoring (CGM) patch market size is expected to see rapid growth in the next few years. It will grow to $12.14 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth during the forecast period can be attributed to increasing prediabetes screening and earlier diagnosis, expanded coverage for insulin and non-insulin users, value-based care incentives linked to time in range outcomes, aging populations with higher metabolic disease burden, and urbanization and dietary transitions in emerging economies. Key trends in the forecast period include extended-wear patch sensors beyond two weeks, integration of automated insulin delivery with patch-based continuous glucose monitoring, direct-to-watch connectivity without relying on smartphones, on-body vibration and discreet alert innovations, and advanced biocompatible adhesives that reduce skin irritation.
The rising prevalence of diabetes is expected to drive the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or insulin resistance. Its prevalence is increasing as rising obesity rates lead to higher insulin resistance, disrupting blood sugar regulation and significantly increasing the risk of developing type 2 diabetes. Real-time blood glucose CGM patches enable people with diabetes to continuously monitor glucose levels, providing timely alerts for hyperglycemia or hypoglycemia, supporting informed dietary, medication, and lifestyle decisions, and improving overall disease management while reducing complication risks. For example, in June 2024, the National Health Service in the UK reported that in 2023, over 549,000 additional individuals in England were identified at risk of type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia or prediabetes registered with a GP to 3,615,330, up nearly 20% from 3,065,825 in 2022. This demonstrates how the rising prevalence of diabetes is driving market growth.
Key companies in the real-time blood glucose CGM patch market are focusing on innovative products such as over-the-counter continuous glucose monitoring sensors to increase access and convenience. Over-the-counter CGM sensors are wearable devices that track glucose levels in real time without a prescription, enabling users to continuously monitor glucose, understand lifestyle impacts, and manage or prevent diabetes more easily. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, launched Stelo, its first OTC CGM patch in the United States. The small, wearable sensor attaches to the back of the upper arm and provides real-time glucose readings directly to a smartphone app without fingersticks. Designed for people with type 2 diabetes not using insulin and those with prediabetes, Stelo delivers personalized insights on how diet, exercise, and sleep affect glucose levels. The device offers up to 15-day wear, waterproofing, spike and pattern detection, and integrates with Dexcom's glucose sensing technology, making continuous glucose monitoring more accessible and actionable for a wider population.
In January 2024, Trinity Biotech plc, an Ireland-based diagnostics company, acquired the biosensor and CGM assets of Waveform Technologies Inc. for $12.5 million in cash and 9 million ADSs. This acquisition enables Trinity Biotech to enter the growing biosensor and CGM market by leveraging Waveform's needle-free CGM technology to develop next-generation wearable biosensors, target additional biomarkers, and promote broader global adoption of affordable diabetes care tools. Waveform Technologies Inc. is a US-based company specializing in real-time blood glucose CGM patch technology.
Major players in the real-time blood glucose continuous glucose monitoring (CGM) patch market are F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic plc, Dexcom Inc., Trinity Biotech plc, Biolinq Inc., Ascensia Diabetes Care Holdings AG, Senseonics Holdings Inc., A. Menarini Diagnostics S.r.l., RSP Systems A/S, OrSense Ltd., Rockley Photonics Holdings Ltd., Sinocare Inc., CNOGA Medical Ltd., Medtrum Technologies Inc., Nutromics Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Movano Health Inc., and GlucoRx Ltd.
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in real-time blood glucose continuous glucose monitoring (CGM) patch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the real-time blood glucose continuous glucose monitoring (CGM) patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as remote patient monitoring and telehealth support, subscription and replacement programs, distribution and logistics management, clinical and diagnostic glucose monitoring services, research and development for sensor innovation, customer training and technical support, and reimbursement or healthcare partnership services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of microneedles paper-type biodegradable sensor, disposable patch sensor, and adhesive-backed sensor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on real-time blood glucose continuous glucose monitoring (cgm) patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for real-time blood glucose continuous glucose monitoring (cgm) patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time blood glucose continuous glucose monitoring (cgm) patch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
4. Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Growth Analysis And Strategic Analysis Framework
5.1. Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
13.1. Indonesia Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market
14.1. South Korea Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Overview
14.2. South Korea Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market
15.1. Western Europe Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Overview
15.2. Western Europe Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.1. Russia Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market
23.1. North America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Overview
23.2. North America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market
26.1. South America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Overview
26.2. South America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
